Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials.

Kumar, Subodh; Saikia, Dibyajyoti; Bankar, Mangesh; Saurabh, Manoj Kumar; Singh, Harminder; Varikasuvu, Sheshadri Reddy; Maharshi, Vikas

Kumar, Subodh; Saikia, Dibyajyoti; Bankar, Mangesh; Saurabh, Manoj Kumar; Singh, Harminder; Varikasuvu, Sheshadri Reddy; Maharshi, Vikas.

Afiliação

Kumar S; Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India.
Saikia D; Department of Pharmacology, AIIMS, Guwahati, India.
Bankar M; Department of Pharmacology, All India Institute of Medical Sciences, Raebareli, India.
Saurabh MK; Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India.
Singh H; Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India.
Varikasuvu SR; Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, India.
Maharshi V; Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India. vikas.maharshi81@gmail.com.

Pharmacol Rep ; 74(6): 1228-1237, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36342658

Assuntos

Vacinas contra COVID-19; COVID-19; Humanos; Metanálise em Rede; Vacina de mRNA-1273 contra 2019-nCoV; COVID-19/prevenção & controle; SARS-CoV-2; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

Coronavirus disease 2019; Efficacy; Network meta-analysis; Vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google